Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Cornerstone Therapeutics Inc.
WARNING LETTER
•Cornerstone Therapeutics Inc.

Cornerstone Therapeutics Inc. – FDA Warning Letter

Record Details

This FDA Warning Letter (10-ATL-03) was issued to Mr. Collard, following an inspection of a contract manufacturer, (b)(4), in (b)(4). The letter states that Mr. Collard's firm contracted with (b)(4) to manufacture drug products, including (b)(4) and (b)(4), which Mr. Collard's firm distributes.

The FDA determined these products are "new drugs" under section 201(p) of the Act [21 U.S.C. § 321(p)] because they are not generally recognized as safe and effective. They lack FDA-approved applications, violating sections 301(d) and 505(a) of the Act [21 U.S.C. §§ 331(d) and 355(a)].

Furthermore, these prescription drug products are misbranded under section 502(f)(1) of the Act [21 U.S.C. § 352(f)(1)] because they lack adequate directions for use by a layman, as required by 21 C.F.R. § 201.5, and are not exempt under 21 C.F.R. § 201.115. The introduction of these products into interstate commerce without approved applications violates sections

Company
Cornerstone Therapeutics Inc.
Product type
Drugs
Office
Atlanta District Office
People
  • Anne P. Reid
  • Philip S. Campbell
View Company Profile

ID · 11762ce0-e13a-4ee2-9f0e-c57607d16fc9

Violation Codes10
21 U.S.C. 321(g)21 U.S.C. 351(a)(2)(B)21 U.S.C. 331(a)21 U.S.C. 321(p)21 U.S.C. 331(d)21.U.S.C. 355(a)21 U.S.C. 355(b)21 U.S.C. 352(f)(1)21 CFR 201.521 CFR 201.115

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Cornerstone Therapeutics Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.